BR9708316A - Aglomerados - Google Patents

Aglomerados

Info

Publication number
BR9708316A
BR9708316A BR9708316A BR9708316A BR9708316A BR 9708316 A BR9708316 A BR 9708316A BR 9708316 A BR9708316 A BR 9708316A BR 9708316 A BR9708316 A BR 9708316A BR 9708316 A BR9708316 A BR 9708316A
Authority
BR
Brazil
Prior art keywords
agglomerates
Prior art date
Application number
BR9708316A
Other languages
English (en)
Inventor
Johannes Raneburger
Erich Ziesl
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AT47496A external-priority patent/AT407214B/de
Priority claimed from AT144596A external-priority patent/AT407701B/de
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of BR9708316A publication Critical patent/BR9708316A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
BR9708316A 1996-03-13 1997-03-13 Aglomerados BR9708316A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT47496A AT407214B (de) 1996-03-13 1996-03-13 Verfahren zur herstellung von hilfsstoffefreien agglomeraten aus beta-lactamantibiotika
AT144596A AT407701B (de) 1996-08-12 1996-08-12 Zur direkttablettierung geeignete mischung, die als wesentliche komponenten amoxicillin-trihydrat und das kaliumsalz der clavulansäure enthält und verfahren zur herstellung dieser mischung
PCT/EP1997/001269 WO1997033564A1 (en) 1996-03-13 1997-03-13 Agglomerates containing beta-lactam compounds

Publications (1)

Publication Number Publication Date
BR9708316A true BR9708316A (pt) 1999-08-03

Family

ID=25592858

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9708316A BR9708316A (pt) 1996-03-13 1997-03-13 Aglomerados

Country Status (21)

Country Link
US (1) US6440462B1 (pt)
EP (2) EP0896526A1 (pt)
JP (1) JP3822246B2 (pt)
KR (1) KR100468204B1 (pt)
CN (1) CN1160058C (pt)
AU (1) AU715682B2 (pt)
BR (1) BR9708316A (pt)
CA (1) CA2245094C (pt)
CZ (1) CZ298815B6 (pt)
ES (1) ES2193899T1 (pt)
HU (1) HUP9900983A3 (pt)
ID (1) ID16237A (pt)
IL (1) IL125492A0 (pt)
NO (1) NO326821B1 (pt)
NZ (1) NZ331178A (pt)
PL (1) PL187761B1 (pt)
RU (1) RU2195265C2 (pt)
SK (1) SK286749B6 (pt)
TR (1) TR199801824T2 (pt)
TW (1) TWI225402B (pt)
WO (1) WO1997033564A1 (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU9540898A (en) * 1997-08-29 1999-03-22 Dsm N.V. Granules free of excipients
US6177421B1 (en) * 1999-05-04 2001-01-23 Fuisz International Ltd. Amoxicillin and clavulanate composition
WO2000025751A2 (en) * 1998-10-30 2000-05-11 Fuisz International Ltd. Improved amoxycillin and clavulanate composition
CN1209099C (zh) * 1999-04-01 2005-07-06 Dsm公司 结晶化附聚物
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
US6358526B1 (en) * 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20040132712A1 (en) * 2001-04-12 2004-07-08 Otto Damon Pharmaceutical compositions comprising clavulanic acid
AT500134A1 (de) * 2002-02-01 2005-11-15 Sandoz Ag Verfahren zur herstellung eines entmischungsstabilen granulats
AT500131A1 (de) * 2002-02-01 2005-11-15 Sandoz Ag Organische verbindungen
AT500132A1 (de) * 2002-02-06 2005-11-15 Sandoz Ag Organische verbindungen
WO2003063820A2 (en) * 2002-02-01 2003-08-07 Sandoz Gmbh Demixing-stable granulate
AT500133A1 (de) * 2002-02-06 2005-11-15 Sandoz Ag Verfahren zur herstellung eines entmischungsstabilen granulats
EP1581191A1 (en) * 2002-11-26 2005-10-05 LEK Pharmaceuticals D.D. Pharmaceutical compositions comprising amoxicillin and clavulanic acid
KR101075700B1 (ko) 2003-03-21 2011-10-21 디에스엠 아이피 어셋츠 비.브이. 아목시실린 트리하이드레이트
CN102260278B (zh) * 2003-03-21 2015-05-06 中化帝斯曼制药有限公司荷兰公司 三水羟氨苄青霉素结晶粉末
US7534781B2 (en) * 2003-03-21 2009-05-19 Dsm Ip Assets B.V. Crystalline amoxicillin trihydrate powder
CA2533178C (en) 2003-07-21 2014-03-11 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005009364A2 (en) 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
CA2533292C (en) 2003-07-21 2013-12-31 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
WO2005016311A1 (en) 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
AU2004264356B2 (en) 2003-08-12 2011-01-27 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP5686494B2 (ja) * 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
EP1663169A4 (en) 2003-09-15 2010-11-24 Middlebrook Pharmaceuticals In ANTIBIOTICS, ITS USE AND FORMULATION
ES2531598T3 (es) * 2004-06-30 2015-03-17 Dsm Sinochem Pharmaceuticals Netherlands B.V. Gránulos que comprenden un antibiótico de ß-lactama
JP2008505124A (ja) 2004-07-02 2008-02-21 アドバンシス ファーマスーティカル コーポレイション パルス送達用錠剤
WO2006072577A1 (en) * 2005-01-07 2006-07-13 Sandoz Ag Process for preparing granulates comprising amoxicillin
US8778924B2 (en) 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
WO2014071283A1 (en) * 2012-11-02 2014-05-08 University Of Kansas Cephalosporin derivatives and methods of use
WO2015032711A1 (en) * 2013-09-03 2015-03-12 Dsm Sinochem Pharmaceuticals Netherlands B.V. Micronized amoxicillin
KR101983170B1 (ko) * 2014-05-19 2019-05-28 삼성전기주식회사 모바일 기기용 저항 조립체 및 그 제조 방법
CN104473892B (zh) * 2014-12-25 2017-08-15 辰欣药业股份有限公司 一种用于直接压片的法罗培南钠组合物及其制备方法
CN107875136B (zh) * 2017-12-27 2021-03-05 广州白云山医药集团股份有限公司白云山制药总厂 一种阿莫西林药物制剂及其制备方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH434571A (de) * 1966-07-05 1967-04-30 Chemical And Pharmaceutical Pa Verfahren zur Herstellung von Antibiotika mit verlängerter therapeutischer Wirkung
GB1166958A (en) 1967-05-22 1969-10-15 Monsanto Chemicals Process for Making Tablets Containing Aspirin and Salicylamide
US3551457A (en) 1968-10-22 1970-12-29 Gen Mills Inc Free-flowing form of tocopheryl succinate
DE2251250C3 (de) * 1972-10-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten
GB1520247A (en) 1974-08-10 1978-08-02 Fisons Ltd Pelletised medicament formulations
FR2282258A1 (fr) * 1974-08-19 1976-03-19 Merck & Co Inc Procede de preparation de comprimes a forte teneur en chlorhydrate de d-(-)-alpha-aminobenzylpenicillinate de pivaloyloxymethyle
US4143129A (en) * 1975-10-11 1979-03-06 Lilly Industries Limited Cephalexin tablets
JO984B1 (en) 1977-10-11 1979-12-01 بيتشام غروب ليمتد A dry pharmaceutical compound with a suitable dosage unit for oral administration
EP0080862B1 (en) 1981-12-02 1985-09-25 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
JPS6238A (ja) 1985-03-12 1987-01-06 Sankyo Co Ltd 混合ビタミン凍結乾燥製剤の製法
GB8606762D0 (en) 1986-03-19 1986-04-23 Boots Co Plc Therapeutic agents
DE3636209A1 (de) 1986-10-24 1988-04-28 Lentia Gmbh Verfahren zur herstellung eines bindemittelfreien tablettierfaehigen celiprololhydrochlorid-granulates
US5288861A (en) * 1987-01-29 1994-02-22 Beecham Group Plc Potassium clavulanate in rosette form
DE3887179T2 (de) 1987-03-02 1994-06-16 Brocades Pharma Bv Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
DE3712058A1 (de) 1987-04-09 1988-10-20 Boehringer Ingelheim Kg Theophyllinhaltige pharmazeutische formen
ES2060737T3 (es) * 1988-02-25 1994-12-01 Yamanouchi Europ Bv Procedimiento de preparacion de un granulado farmaceutico.
GB8909793D0 (en) 1989-04-28 1989-06-14 Beecham Group Plc Pharmaceutical formulation
DE3927810A1 (de) 1989-08-23 1991-02-28 Basf Ag Riboflavingranulate
DE3929864A1 (de) 1989-09-08 1991-03-14 Nordmark Arzneimittel Gmbh Verfahren zur herstellung von theophyllin-pellets
DE4014262A1 (de) 1990-05-04 1991-11-07 Basf Ag Gut rieselfaehige, nichtstaubende bindemittelfreie riboflavinspruehgranulate oder -mikrogranulate aus reinem riboflavin und ein verfahren zu deren herstellung
FR2669221B1 (fr) 1990-11-15 1993-01-15 Rhone Poulenc Sante Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique.
GB9109862D0 (en) 1991-05-08 1991-07-03 Beecham Lab Sa Pharmaceutical formulations
US5191114A (en) 1991-10-09 1993-03-02 Sage Pharmaceuticals, Inc. Process for enhancing the flow characteristics of ibuprofen
DE4231493A1 (de) 1992-09-21 1994-03-24 Nordmark Arzneimittel Gmbh Verfahren zur Herstellung von Pellets aus einem Ephedrinderivat
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
IL109770A0 (en) 1993-05-29 1994-11-28 Smithkline Beecham Corp Thermal infusion process for preparing controlled release solid dosage forms of medicaments for oral administration and controlled release solid dosage forms of medicaments prepared thereby
AT401871B (de) 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
FR2717387B1 (fr) 1994-03-17 1996-10-18 Hi Pharmtech Procédé de fabrication de comprimés à croquer à base de troxérutine, de carbonate de calcium, de phosphate de calcium, d'aspartate d'arginine, de glutamate d'arginine d'amoxicilline.
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
GB9416600D0 (en) 1994-08-17 1994-10-12 Smithkline Beecham Plc Pharmaceutical formulation
ES2175073T3 (es) * 1995-02-08 2002-11-16 Yamanouchi Europ Bv Procedimiento de preparacion de formas para la administracion oral de antibioticos beta-lactamicos de rapida dispersabilidad en agua.
DE19510130C1 (de) 1995-03-21 1996-11-21 Asta Medica Ag Verfahren zur Herstellung rieselfähiger R,S-Thioctsäure, R,S-Thioctsäure sowie deren Verwendung
US5686632A (en) 1996-08-14 1997-11-11 Henkel Corporation Method of producing a tocopherol product

Also Published As

Publication number Publication date
SK286749B6 (sk) 2009-04-06
JP2000501112A (ja) 2000-02-02
PL328400A1 (en) 1999-01-18
NZ331178A (en) 2000-06-23
TWI225402B (en) 2004-12-21
KR19990087104A (ko) 1999-12-15
AU715682B2 (en) 2000-02-10
WO1997033564A1 (en) 1997-09-18
CZ298815B6 (cs) 2008-02-13
JP3822246B2 (ja) 2006-09-13
HUP9900983A3 (en) 1999-11-29
NO983904L (no) 1998-08-25
RU2195265C2 (ru) 2002-12-27
US6440462B1 (en) 2002-08-27
CZ291698A3 (cs) 1998-12-16
NO326821B1 (no) 2009-02-23
EP0896526A1 (en) 1999-02-17
CN1213298A (zh) 1999-04-07
SK124498A3 (en) 1999-01-11
CA2245094A1 (en) 1997-09-18
EP1283034A3 (en) 2003-03-05
EP1283034A2 (en) 2003-02-12
HUP9900983A2 (hu) 1999-08-30
TR199801824T2 (xx) 1998-12-21
KR100468204B1 (ko) 2005-06-17
NO983904D0 (no) 1998-08-25
ES2193899T1 (es) 2003-11-16
ID16237A (id) 1997-09-11
CN1160058C (zh) 2004-08-04
CA2245094C (en) 2007-09-25
IL125492A0 (en) 1999-03-12
PL187761B1 (pl) 2004-10-29
AU2156097A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
BR9708316A (pt) Aglomerados
ATE208395T1 (de) Thiophenopyrimidine
DK0922036T3 (da) Arylalkanoylpyridaziner
ID18010A (id) Oligosakarida termodifikasi
ATE208773T1 (de) Chinoxalindione
ATE353652T1 (de) Östroprogestatives antikonzeptionsmittel
DK0936872T4 (da) Slik-legetöj
BR9708716A (pt) 3-cianoaril-pirazóis
DE29613542U1 (de) Stafflei
DE29616413U1 (de) Schließe
ATE267568T1 (de) Epithese
BR7601508U (pt) Cogafa
BR7600030U (pt) Cinturita
BR9606252A (pt) Cromosauna
BR7601926U (pt) Sofá-mesa
BR9603887A (pt) Fix-imobi
BR9603698A (pt) Hidro-escova dorso-lombar
BR9603463A (pt) Hidro-coleta
BR7601509U (pt) Gafa
BR9603975A (pt) Fix-catch
BR9603976A (pt) Stop-entope
BR9602174A (pt) Lecton massoterapeutico
BR7601419U (pt) Mourao
BR9601152A (pt) Drenovaporvia
BR9600920A (pt) Otimizador-turbinado-nb

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/1997, OBSERVADAS AS CONDICOES LEGAIS.

B25F Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement

Owner name: BIOCHEMIE GESELLSCHAFT M.B.H. (AT)

Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 18130005792/SP, DE 22/02/2013, E NECESSARIO APRESENTAR O DOCUMENTO COM A DEVIDA LEGALIZACAO CONSULAR, ALEM DA GUIA DE CUMPRIMENTO DE EXIGENCIA.

B25E Requested change of name of applicant rejected

Owner name: BIOCHEMIE GESELLSCHAFT M.B.H. (AT)

Free format text: INDEFERIDO O PEDIDO DE ALTERACAO DE NOME CONTIDO NA PETICAO 18130005792/SP DE 22/02/2013, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2226, DE 03/09/2013.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]